Coordinated care involving mental, social and physical aspects is especially necessary for children

and adolescents. Such care should involve not only doctors, but also nurses, psychotherapists, dietitians, social workers, teachers, and other Angiogenesis inhibitor appropriate professionals. Bibliography 1. McDonald SP, et al. N Engl J Med. 2004;26:2654–62. (Level 4)   2. Butani L, et al. Transplantation. 2011;91:447–51. (Level 4)   3. Sinha R, et al. Pediatr Transplant. 2010;14:583–8. (Level 4)   4. Nishikawa K, et al. Clin RepSox cell line Transpl. 2002;367–77. (Level 4)   5. Chung AW, et al. Nephrol Dial Transplant. 2010;25:4031–41. (Level 4)   6. Buyan N, et al. Pediatr Nephrol. 2010;25:1487–96. (Level 4)   7. Pape L, et al. Transplant Proc. 2006;38:685–7. (Level 4)   8. Icard P, et al. Pediatr Transplant. 2010;14:887–90. (Level 4)   9. Shroff R, et al. Pediatr Nephrol. 2009;24:463–74. (Level 4)   10. Yata N, et al. Pediatr Nephrol. 2004;19:1062–64. (Level 5)   11. Tyden G, et al. Pediatr Transplant. 2011;15:502–4. (Level 4)   12. Kennedy SE, et al. Transplantation. 2006;82:1046–50. (Level 4)   Chapter 18: Initiation of dialysis When should general physicians refer their CKD patients to specialists in order to delay the timing for renal replacement therapies? It has been reported that the risk of cardiovascular events and the rate of worsening of renal function significantly

increased in CKD patients selleck products when their eGFR was reduced to less than 50 ml/min/1.73 m2. Therefore, early referral of such patients to nephrologists is usually recommended. However suitable timing of the referral remains uncertain. To our knowledge, no prospective studies have been conducted to directly address this question. Some small, retrospective or uncontrolled studies indicated that early referral at CKD stage G3 or greater can slow down the

course of renal disease, which may consequently delay the timing for renal replacement therapies and ultimately, related mortality. Other retrospective studies also have indicated that early referral has some advantages after the initiation of renal replacement therapies, such as decreasing complications and improving survival. There have been some studies demonstrating that early treatment at a nephrology clinic with a multidisciplinary Resveratrol team (such as a pharmacy specialist, a diabetes educator, a dietitian, a social worker, and a nephrology nurse) may slow the decline in the patient’s renal function. Additional prospective studies are needed to establish the usefulness of early referral in delaying the timing of renal replacement therapies. Bibliography 1. Black C, et al. Health Technol Assess. 2010;14:1–184. (Level 4)   2. Orlando LA, et al. N C Med J. 2007;68:9–16. (Level 4)   3. Nakamura S, et al. Circ J. 2007;71:511–6. (Level 4)   4. Chen SC, et al. Nephrology (Carlton). 2008;13:730–6. (Level 4)   5. Jones C, et al. Nephrol Dial Transplant. 2006;21:2133–43. (Level 4)   6. Martinez-Ramirez HR, et al.